
GC36604
MF-438
Also known as 2-methyl-5-[6-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridazin-3-yl]-1,3,4-thiadiazole
MF-438 is a potent and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor with an IC50 of 2·3 nM for rSCD1
ChemicalCAS921605-87-0MW421.44FormulaC19H18F3N5OS
- CAS number
- 921605-87-0
- Molecular weight
- 421.44
- Formula
- C19H18F3N5OS
- Solubility
- DMSO: 62·5 mg/mL (148·30 mM)
- InChIKey
- NVUJDKDVOZVALT-UHFFFAOYSA-N
- Catalogue number
- GC36604
- Brand
- GLPBIO
Computed properties PubChem CID 16042458 · XLogP 3.9 · TPSA 92.3 Ų · H-bond donors 0
- XLogP
- 3.9
- TPSA
- 92.3 Ų
- H-bond donors
- 0
- H-bond acceptors
- 10
- Rotatable bonds
- 4
- Heavy atoms
- 29
SMILES CC1=NN=C(S1)C2=NN=C(C=C2)N3CCC(CC3)OC4=CC=CC=C4C(F)(F)F
Computed descriptors from PubChem (CID 16042458), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il